News

Public · Published

Palantir's First $2 Billion Quarter Can't Lift the Stock

Palantir reported revenue up 96% to $2.313 billion, its first quarter above $2 billion, beating the $2.177 billion analyst consensus. Adjusted and GAAP earnings per share were both $0.44, above the $0.41 estimate. Total contract value grew just 6% to $2.918 billion.

Published:

Updated:

What happened

Palantir reported revenue up 96% to $2.313 billion, its first quarter above $2 billion, beating the $2.177 billion analyst consensus. Adjusted and GAAP earnings per share were both $0.44, above the $0.41 estimate. Total contract value grew just 6% to $2.918 billion.

Confirmed

Global impact / market context

The 5.13% premarket decline shows investors focused on the 6% rise in total contract value, which measures the value of signed deals, rather than on strong current revenue and profit. Slower deal growth suggests future sales may arrive more slowly, which can outweigh a good quarter and pressure the stock even when results beat estimates.

Analyst inference

Palantir pairs rapid revenue growth with a rich valuation, so expectations are high. A quarter that beats on sales and profit but shows weaker new-contract growth can trigger selling as investors question whether the growth rate is sustainable, especially with U.S. commercial revenue now larger than U.S. government revenue for the first time.

Analyst inference

What to watch

  1. Full-year revenue guidance was raised to $8.530 billion to $8.534 billion, or 91% growth, and adjusted free cash flow guidance to $4.8 billion to $5.0 billion, which is cash left after running and investing in the business. Confirmed
  2. Watch whether total contract value growth reaccelerates toward revenue growth in coming quarters; if bookings keep lagging, the gap may signal slower future sales and could weigh on the stock. Proposed
  3. Track U.S. commercial revenue, guided above $3.559 billion for at least 143% growth, and net dollar retention of 165%; a slowdown there would undercut the growth story that supports the valuation. Analyst inference

Evidence